{"id":"NCT01432262","sponsor":"Pfizer","briefTitle":"13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico","officialTitle":"A Phase 3, Open Label, Single Arm, Multicenter, Trial to Assess The Safety, Tolerability And Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine In Healthy Adults Aged => 50 Years of Age Who Are Naive To 23-Valent Pneumococcal Polysaccharide Vaccine in Mexico.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07","primaryCompletion":"2011-12","completion":"2011-12","firstPosted":"2011-09-12","resultsPosted":"2013-01-08","lastUpdate":"2013-01-25"},"enrollment":324,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Infections"],"interventions":[{"type":"BIOLOGICAL","name":"vaccine-13vPnC","otherNames":["13-valent pneumococcal conjugate vaccine"]},{"type":"BIOLOGICAL","name":"vaccine-13vPnC","otherNames":["13-valent pneumococcal conjugate vaccine"]}],"arms":[{"label":"Group 1","type":"EXPERIMENTAL"},{"label":"Group 2","type":"EXPERIMENTAL"}],"summary":"The purpose of this study will be to assess the safety, tolerability, and immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) when given to healthy adults older than 50 years of age who haven't received 23-valent pneumococcal polysaccharide vaccine in Mexico.","primaryOutcome":{"measure":"Serotype-Specific Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After Vaccination","timeFrame":"One month (28 to 42 days) after vaccination","effectByArm":[{"arm":"13vPnC, Cohort 1","deltaMin":120,"sd":null},{"arm":"13vPnC, Cohort 2","deltaMin":84,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":4,"countries":["Mexico"]},"refs":{"pmids":["25499011"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1851048&StudyName=13-valent%20Pneumococcal%20Conjugate%20Vaccine%20Study%20in%20Adults%20%3D%3E%2050%20Years%20of%20Age%20in%20Mexico"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":162},"commonTop":["Pain at injection site Any","Pain at injection site Mild","Muscle pain Any","Muscle pain Mild","Fatigue Any"]}}